A new technology developed by researchers from King’s College London (KCL) could provide a new way of delivering drugs to advance next-generation treatments to prevent and treat a variety of diseases.

Vicore Pharma and Endeavor BioMedicines have shared new data from two mid-stage clinical trials of two therapies that show promise in treating patients living with idiopathic pulmonary fibrosis (IPF).

A new analysis led by the UK Health Security Agency (UKHSA) and Imperial College London (ICL) has confirmed that a variant called M1UK played a key role in the global increase of group A Streptococcus ...

The autoimmune disease, which affects 1.5 million people in the US, causes the body's immune system to attack its own tissues Researchers from Johns Hopkins Medicine have revealed that certain ...

Researchers from Imperial College London (ICL), the Alan Turing Institute and the Universities of Sheffield and Nottingham are aiming to develop and test the first-ever ‘digital twin’ heart models for ...

Heart failure is a cardiovascular disease that affects more than 64 million people worldwide A study led by researchers from the University of Glasgow has revealed that a brand-new heart failure ...

The funding will help to support research across epigenetics, immunology and cell signalling The Biotechnology and Biological Sciences Research Council (BBSRC) has invested £48m into the Babraham ...

Both awards are open for entry until 17 May 2024 and the live awards ceremony will take place on 11 July 2024 PharmaTimes is excited to announce the re-launch of two exciting awards: the Medical & ...

Total-body PET imaging platform set to enhance scope of research into complex diseases and improve patient outcomes ...

Go to the App Store or Google Play and search for ‘PharmaTimes’ to download our free app.

For the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer The NHS has announced, for the second month in a row, that it has met the 28-day faster diagnosis target ...

GPT-4 is trained on datasets to offer eye-related advice, diagnosis and management suggestions A new study led by researchers from the University of Cambridge has revealed that an artificial ...